Piobacteriophage complex liquid, 100 ml

Name: Piobacteriophage complex liquid, 100 ml
SKU: 210995
Availability: OutOfStock

€1.00

Out of stock

(E-mail when Stock is available)

EAN: 4605021002680 SKU: 210995 Categories: Immune system, Medicine

Description

Piobacteriophage liquid complex is a drug with specific selective antibacterial action. Piobacteriophage is active against strains of Streptococcus, Proteus, Staphylococcus, Enterococcus, Occitox, Pseudomonas pneumoniae, Klebsiella pneumoniae and E. coli.

Phiobacteriophage lyses sensitive bacteria due to its ability to attach to their membrane and penetrate the cell. Phage particles multiply in the bacterial cell at the expense of the energy resources of the microorganisms, which leads to their death.

After the death of the bacterial cell, mature phage particles emerge, capable of infecting other susceptible microorganisms.

Phiobacteriophage has no effect on other types of bacteria and does not cause disruption of the natural microflora.

Indications

Colds, Tracheitis, Respiratory tract infections, Bursitis, Purulent wounds, Boils, Urethritis, Enteritis, Lung inflammation (pneumonia), Dysbacteriosis, Osteomyelitis, Bronchitis, Cholecystitis

Treatment and prevention of purulent inflammatory and intestinal diseases caused by staphylococci, enterocococci, streptococci, Pseudomonas, Klebsiella, pathogenic E. coli of different serogroups, Proteus when applied internally, rectally and externally:

Diseases of the ear, throat, nose, respiratory tract and lungs: inflammation of the sinuses, middle ear, sore throat, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy.
Urogenital infections: urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingoophoritis.
Post-traumatic conjunctivitis, keratoconjunctivitis, purulent corneal ulcers and iridocyclitis.
Entral infections: gastroenterocolitis, cholecystitis, dysbacteriosis.
Generalized septic diseases.
Purulent inflammatory diseases of newborns: omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc..
Other diseases caused by bacteria staphylococci, streptococci, enterocococci, Proteus, Klebsiella pneumoniae and oxytocin, Pseudomonas and E. coli.

For preventive purposes the drug is used for treatment of surgical and freshly infected wounds as well as for prevention of nosocomial infections for epidemic indications.

The important condition for effective phagotherapy is the prior determination of the phage sensitivity of the causative agent.

Active ingredient

Piobacteriophage

Composition

The solution contains:

Active ingredients:

A mixture of sterile filtrates of phagolysates of staphylococci,

Streptococci,

enterococci,

Proteus,

Klebsiella (pneumoniae and oxytocin),

100 ml of Pseudomonas and Escherichia coli.

How to take, the dosage
How to take, the dosage
Piobacteriophage is intended for local and oral administration as well as for rectal administration.
The treatment of purulent inflammatory processes is recommended by simultaneous local administration and oral administration of Piobacteriophage.
Depending on the localization of the infection, Piobacteriophage is recommended for:
1. Topical application in the form of lotions, irrigations, applications and swabs, moistened solutions. In this case, use the necessary amount of solution, based on the size of the affected area. For abscesses, the solution should be injected into the cavity after removal of pus by puncture (the volume of the solution should be slightly less than the volume of the extracted pus).
2. After administration of necessary amount of bacteriophage a capillary drainage shall be left for subsequent administration of repeated doses of the drug.
3. injection of solution into drained cavity of urinary bladder and renal pelvis through cystostoma or nephrostoma.
4. injection of solution into uterine or vaginal cavity, including tampons soaked in solution.
5. Injection, irrigation and gargling as well as insertion of solution-soaked turundae in otolaryngological practice.
6. Injection into the conjunctival sac in ophthalmological practice.
7. Introduction of moistened turundas into periodontal pockets in dental practice.
8. Injection into the rectum in the form of enemas in gastroenterological practice.
The dose of the drug Piobacteriophage and the duration of therapy is determined by the doctor.
The single dose recommended for children under 6 months of age is 5 ml if administered orally or 10 ml if administered rectally.
Recommended single dose for children aged 6-12 months – 10 ml if administered orally and 20 ml if administered rectally.
Recommended single dose for children aged 1-3 years – 15 ml if administered orally and 30 ml if administered rectally.
Recommended single dose for children aged 3-8 years old – 20 ml if given orally and 40 ml if given rectally.
Recommended single dose for children over 8 years old and adults – 30 ml if given orally and 50 ml if given rectally.
When treating pyo-inflammatory diseases and bowel diseases the appropriate single dose is usually administered three times a day.
If when using bacteriophage locally the wound was previously treated with antiseptic, it is necessary to wash the wound with 0.9% sodium chloride solution before using Piobacteriophage solution.
In children under 6 months of age with enterocolitis and sepsis Piobacteriophage solution is administered in the form of high enemas twice or three times a day. If the child does not develop regurgitation and vomiting the drug can be given orally.
The average duration of therapy is from 5 to 15 days.
As a preventive measure, the drug is given in a single dose twice a day for 5-7 days.

Interaction
Interaction
The use of the drug is possible in combination with other medicines, including antibiotics.

Special Instructions
Special Instructions
The bottle of liquid bacteriophage should be shaken before use. Do not use if cloudy!

Contraindications
Contraindications
Not available.

Side effects
Side effects
No undesirable effects have been reported with Piobacteriophage.

Overdose
Overdose
There are no treatment measures for overdose.

Pregnancy use
Pregnancy use
Piobacteriophage may be prescribed by the attending physician during pregnancy and while breastfeeding.

Similarities
Similarities
Polyvalent pyobacteriophage

Additional information
Weight 0.225 kg
Shelf life
2 years
Conditions of storage
In a dry, light-protected place at 2-8 °C
Manufacturer
Microgen NPO, Russia
Medication form
oral solution
Brand
Microgen NPO